145 related articles for article (PubMed ID: 38704439)
21. Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.
Bullano MF; Willey V; Hauch O; Wygant G; Spyropoulos AC; Hoffman L
J Manag Care Pharm; 2005 Oct; 11(8):663-73. PubMed ID: 16194130
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular and Venous Thromboembolic Risk With Janus Kinase Inhibitors in Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis of Randomized Trials.
Maqsood MH; Weber BN; Haberman RH; Lo Sicco KI; Bangalore S; Garshick MS
ACR Open Rheumatol; 2022 Oct; 4(10):912-922. PubMed ID: 35903881
[TBL] [Abstract][Full Text] [Related]
23. Predictors of Recurrent Venous Thromboembolism or Arterial Thrombotic Events during and after Anticoagulation for a First Venous Thromboembolism.
Noumegni SR; Tromeur C; Hoffmann C; Mao RL; Moigne EL; Moreuil C; Mansourati V; Nasr B; Gentric JC; Guegan M; Poulhazan E; Bressollette L; Lacut K; Didier R; Couturaud F
Semin Thromb Hemost; 2023 Oct; 49(7):688-701. PubMed ID: 36252603
[TBL] [Abstract][Full Text] [Related]
24. Association Between Anticoagulation Outcomes and Venous Thromboembolism History in Chronic Thromboembolic Pulmonary Hypertension.
Zhu YJ; Zhou YP; Wei YP; Xu XQ; Yan XX; Liu C; Zhu XJ; Liu ZY; Sun K; Hua L; Jiang X; Jing ZC
Front Cardiovasc Med; 2021; 8():628284. PubMed ID: 34095244
[No Abstract] [Full Text] [Related]
25. A narrative review on the epidemiology, prevention, and treatment of venous thromboembolic events in the context of chronic venous disease.
Kemp MT; Obi AT; Henke PK; Wakefield TW
J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1557-1567. PubMed ID: 33866055
[TBL] [Abstract][Full Text] [Related]
26. Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?
Scott IC; Hider SL; Scott DL
Drug Saf; 2018 Jul; 41(7):645-653. PubMed ID: 29500799
[TBL] [Abstract][Full Text] [Related]
27. JAK in the [Black] Box: A Dermatology Perspective on Systemic JAK Inhibitor Safety.
Elmariah SB; Smith JS; Merola JF
Am J Clin Dermatol; 2022 Jul; 23(4):427-431. PubMed ID: 35679017
[TBL] [Abstract][Full Text] [Related]
28. Short-Term Cardiovascular Complications in Dermatology Patients Receiving JAK-STAT Inhibitors: A Meta-Analysis of Randomized Clinical Trials.
Ireland PA; Jansson N; Spencer SKR; Braden J; Sebaratnam D
JAMA Dermatol; 2024 Mar; 160(3):281-289. PubMed ID: 38294793
[TBL] [Abstract][Full Text] [Related]
29. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
30. Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort study.
Desai RJ; Pawar A; Khosrow-Khavar F; Weinblatt ME; Kim SC
Rheumatology (Oxford); 2021 Dec; 61(1):121-130. PubMed ID: 33752237
[TBL] [Abstract][Full Text] [Related]
31. Risk of Venous Thromboembolism Associated With Tofacitinib and Baricitinib: A Systematic Review and Indirect Meta-Analysis.
Giménez Poderós T; Gallardo Borge S; Vazquez-Ferreiro P
Pharmacotherapy; 2020 Dec; 40(12):1248-1264. PubMed ID: 33064892
[TBL] [Abstract][Full Text] [Related]
32. Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism with JAK Inhibitors versus TNF Inhibitors in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis.
Partalidou S; Patoulias D; Deuteraiou K; Avgerou P; Kitas G; Tzitiridou-Chatzopoulou M; Dimitroulas T
Mediterr J Rheumatol; 2024 Mar; 35(Suppl 1):10-19. PubMed ID: 38756933
[TBL] [Abstract][Full Text] [Related]
33. One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events.
Chen SY; Wu N; Gulseth M; LaMori J; Bookhart BK; Boulanger L; Fields L; Schein J
J Manag Care Pharm; 2013 May; 19(4):291-301. PubMed ID: 23627575
[TBL] [Abstract][Full Text] [Related]
34. Janus Kinase Inhibitors in Rheumatoid Arthritis: An Update on the Efficacy and Safety of Tofacitinib, Baricitinib and Upadacitinib.
Harrington R; Harkins P; Conway R
J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892827
[TBL] [Abstract][Full Text] [Related]
35. Treatment of DVT: how long is enough and how do you predict recurrence.
Agnelli G; Becattini C
J Thromb Thrombolysis; 2008 Feb; 25(1):37-44. PubMed ID: 17906973
[TBL] [Abstract][Full Text] [Related]
36. High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.
Whitworth H; Clark HH; Hubbard RA; Witmer C; Leonard CE; Raffini L
J Thromb Haemost; 2023 Jan; 21(1):47-56. PubMed ID: 36695395
[TBL] [Abstract][Full Text] [Related]
37. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
38. A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy.
Fankhauser CD; Tran B; Pedregal M; Ruiz-Morales JM; Gonzalez-Billalabeitia E; Patrikidou A; Amir E; Seidel C; Bokemeyer C; Hermanns T; Rumyantsev A; Tryakin A; Brito M; Fléchon A; Kwan EM; Cheng T; Castellano D; Del Muro XG; Hamid AA; Ottaviano M; Palmieri G; Kitson R; Reid A; Heng DYC; Bedard PL; Sweeney CJ; Connors JM
Eur Urol Focus; 2021 Sep; 7(5):1130-1136. PubMed ID: 33032968
[TBL] [Abstract][Full Text] [Related]
39. Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases.
Kochar BD; Cheng D; Cai T; Ananthakrishnan AN
Dig Dis Sci; 2022 Nov; 67(11):5206-5212. PubMed ID: 35113275
[TBL] [Abstract][Full Text] [Related]
40. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
Huisman MV; Bounameaux H
Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
